These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21256766)

  • 21. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
    Liu MZ; Wang JH; Du J; Huang J; Li LH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Precapillary pulmonary hypertension of uncertain etiology].
    Halank M; Wiemer M; Tschöpe C; Poller W; Schwimmbeck P; Horstkotte D; Höffken G
    Dtsch Med Wochenschr; 1998 Jul; 123(28-29):861-5. PubMed ID: 9693656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pulmonary arterial hypertension and heart transplantation: hemodynamic evolution and survival].
    Delgado Jiménez JF; Gómez-Sánchez MA; Calle Pérez G; Carnero Varo A; Hernández Afonso J; Tascón Pérez J; Llovet Verdugo A; Molina Ruiz L; Rodríguez Hernández E; Sáenz de la Calzada C; Rufilanchas Sánchez JJ
    Rev Esp Cardiol; 1996 Nov; 49(11):804-9. PubMed ID: 9082490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhaled nitric oxide: therapeutic applications in cardiac surgery].
    Estanove S; Girard C; Bastien O; Piriou V; Lehot JJ
    Bull Acad Natl Med; 2000; 184(8):1715-26; discussion 1727-9. PubMed ID: 11471390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation.
    Bourge RC; Kirklin JK; Naftel DC; White C; Mason DA; Epstein AE
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):432-44; discussion 444-5. PubMed ID: 1999936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension.
    Findlay JY; Harrison BA; Plevak DJ; Krowka MJ
    Liver Transpl Surg; 1999 Sep; 5(5):381-7. PubMed ID: 10477839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension.
    Sablotzki A; Czeslick E; Schubert S; Friedrich I; Mühling J; Dehne MG; Grond S; Hentschel T
    Can J Anaesth; 2002 Dec; 49(10):1076-80. PubMed ID: 12477682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low doses of inhaled nitric oxide in heart transplant recipients.
    Auler Júnior JO; Carmona MJ; Bocchi EA; Bacal F; Fiorelli AI; Stolf NA; Jatene AD
    J Heart Lung Transplant; 1996 May; 15(5):443-50. PubMed ID: 8771498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
    Braun S; Schrötter H; Schmeisser A; Strasser RH
    Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biventricular assist devices as a bridge to heart transplantation in small children.
    Gandhi SK; Huddleston CB; Balzer DT; Epstein DJ; Boschert TA; Canter CE
    Circulation; 2008 Sep; 118(14 Suppl):S89-93. PubMed ID: 18824776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative evaluation improves the outcome in heart transplant recipients with pulmonary hypertension--retrospective analysis of 106 cases.
    Zeng Z; Jiang Z; Wang CS; Luo H; Huang YF; Jin XH
    Transplant Proc; 2010 Nov; 42(9):3708-10. PubMed ID: 21094843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S
    J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Heterotropic heart transplantation in young patients with elevated pulmonary vascular resistance].
    Gamba A; Fiocchi R; Mamprin F; Senni M
    G Ital Cardiol; 1999 Aug; 29(8):918-24. PubMed ID: 10488455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary hypertension in heart failure.
    Guglin M; Khan H
    J Card Fail; 2010 Jun; 16(6):461-74. PubMed ID: 20610227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting survival after heterotopic heart transplantation.
    Kawaguchi A; Gandjbakhch I; Pavie A; Muneretto C; Bors V; Leger P; Cabrol A; Desruennes M; Cabrol C
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):928-34. PubMed ID: 2811423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated pulmonary vascular resistance and cardiac transplantation.
    Addonizio LJ; Gersony WM; Robbins RC; Drusin RE; Smith CR; Reison DS; Reemtsma K; Rose EA
    Circulation; 1987 Nov; 76(5 Pt 2):V52-5. PubMed ID: 3311456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined administration of intravenous dipyridamole and inhaled nitric oxide to assess reversibility of pulmonary arterial hypertension in potential cardiac transplant recipients.
    Lepore JJ; Dec GW; Zapol WM; Bloch KD; Semigran MJ
    J Heart Lung Transplant; 2005 Nov; 24(11):1950-6. PubMed ID: 16297803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.